Φορτώνει......
Arbekacin treatment of a patient infected with a Pseudomonas putida producing a metallo-beta-lactamase
Treatment of infections caused by multidrug-resistant Pseudomonas species is difficult because few antibiotics active against such organisms are available. Arbekacin, a relatively new aminoglycoside, is effective against Pseudomonas spp. in vitro. However, no clinical report on arbekacin treatment o...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | J Intensive Care |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
BioMed Central
2013
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4336246/ https://ncbi.nlm.nih.gov/pubmed/25705398 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2052-0492-1-3 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|